(FILES) This photograph taken on January 5, 2023 shows the logo of GSK pharmaceutical laboratory in Mayenne, western France. The British pharmaceutical giant GSK announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by JEAN-FRANCOIS MONIER / AFP via Getty Images)